Literature DB >> 11535550

Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody.

Y Ikehara1, S Nishihara, H Yasutomi, T Kitamura, K Matsuo, N Shimizu, K Inada, Y Kodera, Y Yamamura, H Narimatsu, N Hamajima, M Tatematsu.   

Abstract

Helicobacter pylori attach to the gastric mucosa with adhesin, which binds to Lewis b (Le(b)) or H type I carbohydrate structures. The Secretor (Se) gene and Lewis (Le) gene are involved in type I Le antigen synthesis. The present study was performed to investigate the possibility that Se and Le gene polymorphisms alter the risk of H. pylori infection. Two hundred thirty-nine participants were genotyped for Se and Le and tested for the presence of anti-H. pylori IgG antibodies. Using the normal gastric mucosa from 60 gastric cancer patients, we assessed immunohistochemically whether type I Le antigen expression depended on the Se and Le genotypes. The H. pylori infection rate was positively associated with the number of Se alleles (se/se group, 45.1%; Se/se group, 64.6%; and Se/Se group, 73.3%) and negatively associated with the number of Le alleles (le/le group, 76.4%; Le/le group, 68.3%; and Le/Le group, 55.6%). When the subjects were classified into three groups [low risk, (se/se, Le/Le) genotype; high risk, (Se/Se, le/le), (Se/Se, Le/le), and (Se/se, le/le) genotypes; moderate risk, other than low- or high-risk group], the odds ratio relative to the low-risk group was 3.30 (95% confidence interval, 1.40-7.78) for the moderate-risk group and 10.33 (95% confidence interval, 3.16-33.8) for the high-risk group. Immunohistochemical analysis supported the finding that Se and Le genotypes affected the expression of H. pylori adhesin ligands. We conclude that Se and Le genotypes affect susceptibility to H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535550

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  39 in total

1.  CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.

Authors:  M Kudo; O Gutierrez; H M T El-Zimaity; H Cardona; Z Z Nurgalieva; J Wu; D Y Graham
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

Authors:  Brian M Wolpin; Peter Kraft; Mousheng Xu; Emily Steplowski; Martin L Olsson; Alan A Arslan; H Bas Bueno-de-Mesquita; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea LaCroix; Gloria Petersen; Rachael Z Stolzenberg-Solomon; Wei Zheng; Demetrius Albanes; Naomi E Allen; Laufey Amundadottir; Melissa A Austin; Marie-Christine Boutron-Ruault; Julie E Buring; Federico Canzian; Stephen J Chanock; J Michael Gaziano; Edward L Giovannucci; Göran Hallmans; Susan E Hankinson; Robert N Hoover; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Charles Kooperberg; Julie B Mendelsohn; Dominique S Michaud; Kim Overvad; Alpa V Patel; Maria-José Sanchéz; Leah Sansbury; Xiao-Ou Shu; Nadia Slimani; Geoffrey S Tobias; Dimitrios Trichopoulos; Paolo Vineis; Kala Visvanathan; Jarmo Virtamo; Jean Wactawski-Wende; Joanne Watters; Kai Yu; Anne Zeleniuch-Jacquotte; Patricia Hartge; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-22       Impact factor: 4.254

Review 3.  Human genetic variation and the gut microbiome in disease.

Authors:  Andrew Brantley Hall; Andrew C Tolonen; Ramnik J Xavier
Journal:  Nat Rev Genet       Date:  2017-08-21       Impact factor: 53.242

4.  Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients.

Authors:  Nikola Panic; Elena Mastrostefano; Emanuele Leoncini; Roberto Persiani; Dario Arzani; Rosarita Amore; Riccardo Ricci; Federico Sicoli; Stefano Sioletic; Milutin Bulajic; Domenico D' Ugo; Walter Ricciardi; Stefania Boccia
Journal:  Mol Biol Rep       Date:  2014-02-14       Impact factor: 2.316

Review 5.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

6.  Lewis enzyme (alpha1-3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population.

Authors:  Jacinta Serpa; Raquel Almeida; Carla Oliveira; Filipe Santos Silva; Elisabete Silva; Celso Reis; Jacques Le Pendu; Graça Oliveira; Luís Manuel Cunha Ribeiro; Leonor David
Journal:  J Hum Genet       Date:  2003-03-20       Impact factor: 3.172

Review 7.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

8.  Two new FUT2 (fucosyltransferase 2 gene) missense polymorphisms, 739G-->A and 839T-->C, are partly responsible for non-secretor status in a Caucasian population from Northern Portugal.

Authors:  Jacinta Serpa; Nuno Mendes; Celso A Reis; Luis F Santos Silva; Raquel Almeida; Jacques Le Pendu; Leonor David
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

9.  Children with the Le(a+b-) blood group have increased susceptibility to diarrhea caused by enterotoxigenic Escherichia coli expressing colonization factor I group fimbriae.

Authors:  Tanvir Ahmed; Anna Lundgren; Mohammad Arifuzzaman; Firdausi Qadri; Susann Teneberg; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

10.  Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa.

Authors:  Ana Magalhães; Joana Gomes; Mohd Nazri Ismail; Stuart M Haslam; Nuno Mendes; Hugo Osório; Leonor David; Jacques Le Pendu; Rainer Haas; Anne Dell; Thomas Borén; Celso A Reis
Journal:  Glycobiology       Date:  2009-08-25       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.